Menu

BioXcel Therapeutics, Inc. BTAI

Full chart Compare
Set alert

Price alert · BTAI

All alert types
0.07 USD 0.00 (+0.00%)

At closeSep 4, 2026, 4:00 PM EDT

1.30 +1.23 +1,659.13%

After hours · Sep 4, 4:00 PM ET

0.069 Day range 0.0935
0.30 52-week range 4.17
YTD
-95.38%
1 year
-96.36%

Revenue & Expenses

Revenue → Gross Profit: $478.00KGross Profit → Expenses: $478.00KRevenue → Cost of Revenue: $164.00KExpenses → Selling, General & Admin: $20.49MExpenses → Research & Development: $30.25MExpenses → Interest Expense: $16.98MExpenses → Other Expenses: $2.65MNet Loss → Expenses: $69.90MGross Profit$478.00KNet Loss$69.90MCost of Revenue$164.00KExpenses$70.38MSelling, General & Admin$20.49MResearch & Development$30.25MInterest Expense$16.98MOther Expenses$2.65MRevenue$642.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

BTAI annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
642.00K2.27M1.38M375.00K0
642.00K2.27M1.38M375.00K0
164.00K2.14M1.26M20.00K0
478.00K123.00K120.00K355.00K0
50.94M67.37M171.90M160.00M106.94M
30.25M30.43M84.33M91.24M52.71M
20.49M34.49M83.41M68.76M54.23M
-50.46M-67.25M-171.78M-159.65M-106.94M
16.98M15.13M13.31M8.21M40.00K
-69.90M-59.60M-179.05M-165.76M-106.93M
-69.90M-59.60M-179.05M-165.76M-106.93M
-69.90M-59.60M-179.05M-165.76M-106.93M
-69.90M-59.60M-179.05M-165.76M-106.93M
-5.73-23.51-98.33-95.00-65.00
-5.73-23.51-98.33-95.00-65.00
-5.73-23.51-98.33-95.00-65.00
-52.91M-44.47M-165.74M-157.54M-106.89M
-52.91M-44.47M-165.74M-157.54M-106.89M
12.21M2.54M1.82M1.75M1.65M
12.21M2.54M1.82M1.75M1.65M